Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
New DNA methylation-based method for precise assessment of pancreas cell composition

New DNA methylation-based method for precise assessment of pancreas cell composition

by Hebrew University of JerusalemHistological image of the human pancreas, stained with antibodies against insulin (green) and glucagon (red), together marking an islet of Langerhans. Blue labels

New DNA methylation-based method for precise assessment of pancreas cell composition

by Hebrew University of JerusalemHistological image of the human pancreas, stained with antibodies against insulin (green) and glucagon (red), together marking an islet of Langerhans. Blue labels
Implant survival poor for converted 'partial' knee replacements

Implant survival poor for converted 'partial' knee replacements

(HealthDay)—Total knee arthroplasty (TKA) converted from medial unicompartmental (or "partial") knee arthroplasty (UKA) has a risk for revision that is threefold higher than that for primary

Implant survival poor for converted 'partial' knee replacements

(HealthDay)—Total knee arthroplasty (TKA) converted from medial unicompartmental (or "partial") knee arthroplasty (UKA) has a risk for revision that is threefold higher than that for primary
AI model provides a hypoglycemia early warning system when driving

AI model provides a hypoglycemia early warning system when driving

by Ludwig Maximilian University of MunichControlled hypoglycemia procedures for studies 1 and 2 used variable insulin and glucose administration with corresponding driving sessions in euglycemia

AI model provides a hypoglycemia early warning system when driving

by Ludwig Maximilian University of MunichControlled hypoglycemia procedures for studies 1 and 2 used variable insulin and glucose administration with corresponding driving sessions in euglycemia
High out-of-pocket costs hindering treatment of diabetes

High out-of-pocket costs hindering treatment of diabetes

by University of MichiganHigh out-of-pocket costs hindering treatment of diabetes. Credit: Jacob Dwyer/Michigan MedicineActively managing diabetes is crucial to preventing long-term health compli

High out-of-pocket costs hindering treatment of diabetes

by University of MichiganHigh out-of-pocket costs hindering treatment of diabetes. Credit: Jacob Dwyer/Michigan MedicineActively managing diabetes is crucial to preventing long-term health compli
ACR: walking each day may cut risk for TKA over five years

ACR: walking each day may cut risk for TKA over five years

(HealthDay)—For individuals with knee osteoarthritis (OA), replacing time not walking with walking at moderate-to-vigorous intensity is associated with reduced risk for total knee arthroplasty (TKA) o

ACR: walking each day may cut risk for TKA over five years

(HealthDay)—For individuals with knee osteoarthritis (OA), replacing time not walking with walking at moderate-to-vigorous intensity is associated with reduced risk for total knee arthroplasty (TKA) o
Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

by Bram Sable-Smith, KFF Health NewsCredit: Christina Morillo from PexelsWhen Phyllisa Deroze was told she had diabetes in a Fayetteville, North Carolina, emergency department years ago, she was hande

Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

by Bram Sable-Smith, KFF Health NewsCredit: Christina Morillo from PexelsWhen Phyllisa Deroze was told she had diabetes in a Fayetteville, North Carolina, emergency department years ago, she was hande
Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A
ABT-494 effective for patients with rheumatoid arthritis

ABT-494 effective for patients with rheumatoid arthritis

(HealthDay)—A novel selective JAK-1 inhibitor, ABT-494, is effective for rheumatoid arthritis (RA) patients with inadequate response to methotrexate (MTX) or to at least one anti-tumor necrosis factor

ABT-494 effective for patients with rheumatoid arthritis

(HealthDay)—A novel selective JAK-1 inhibitor, ABT-494, is effective for rheumatoid arthritis (RA) patients with inadequate response to methotrexate (MTX) or to at least one anti-tumor necrosis factor
For diabetes and liver cancer, study suggests new screening guidelines

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...